Epidermal growth factor receptor gene and c‐erbB‐2 gene amplification in ovarian cyst fluid

[1]  B. Casslén,et al.  Fluid Characteristics of Benign Ovarian Cysts: Correlation With Recurrence After Puncture , 1995, Obstetrics and gynecology.

[2]  B. Gerber,et al.  Histologie und Zytologie laparoskopisch operierter „simpler Ovarialzysten“ , 1995 .

[3]  L. Zentilin,et al.  Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. , 1995, Clinical chemistry.

[4]  W. Creasman,et al.  Ovarian cancer screening. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Olson,et al.  Reliability of Differential PCR for the Detection of EGFR and MDM2 Gene Amplification in DNA Extracted from FFPE Glioma Tissue , 1995, Journal of neuropathology and experimental neurology.

[6]  R. Scully,et al.  p53 expression in ovarian borderline tumors and stage I carcinomas. , 1994, American journal of clinical pathology.

[7]  R. Scully,et al.  Early de novo ovarian carcinoma. A study of fourteen cases , 1994, Cancer.

[8]  A. Harłozińska,et al.  Relationship between p53 and c-erbB-2 overexpression in tissue sections and cyst fluid cells of patients with ovarian cancer. , 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[9]  J. Papp,et al.  Oncogene patterns in breast and ovarian carcinomas. , 1993, European Journal of Surgical Oncology.

[10]  S. Leodolter,et al.  HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples. , 1993, European journal of cancer.

[11]  R. Kryscio,et al.  Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. , 1992, Gynecologic oncology.

[12]  B. Ljung,et al.  The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. , 1992, Oncogene.

[13]  A. Neubauer,et al.  Analysis of gene amplification in archival tissue by differential polymerase chain reaction. , 1992, Oncogene.

[14]  R. Ozols,et al.  Ovarian cancer biology. , 1991, Seminars in oncology.

[15]  R. Bast,et al.  Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor , 1991, American journal of obstetrics and gynecology.

[16]  R. Bast,et al.  Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. , 1991, American journal of obstetrics and gynecology.

[17]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[18]  G. Carpenter,et al.  The Epidermal Growth Factor Family , 1991 .

[19]  J. Foekens,et al.  Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  E. Liu,et al.  Detection of amplified oncogenes by differential polymerase chain reaction. , 1989, Oncogene.

[21]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[22]  T. Bauknecht,et al.  Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. , 1988, Gynecologic oncology.

[23]  N. Nomura,et al.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.

[24]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[25]  D. Goeddel,et al.  Structure of the human immune interferon gene , 1982, Nature.